• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD FISHER & PAYKEL HEALTHCARE; NASAL CANNULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD FISHER & PAYKEL HEALTHCARE; NASAL CANNULA Back to Search Results
Model Number OPT944
Medical Device Problem Code Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Low Oxygen Saturation (2477)
Date of Event 03/01/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(6).Fisher & paykel healthcare (f&p) is currently in the process of completing f&p's investigation.F&p will provide a follow up report upon completion of f&p's investigation.Product background: the opt944 optiflow + adult nasal cannula is a nasal cannula patient interface for delivery of humidified respiratory gases, including those who are receiving nasal high flow therapy (nhf).The cannula consists of a lightweight delivery tube connected to a rigid plastic base and soft nasal prongs (nasal interface).This allows the device to be light weight and durable.The interface is held in place by a head strap and features a head strap clip which works in tandem with the tubing clip (attaches to the patient's clothing/bedding) to support the weight of the circuit and prevent the cannula being dislodged.Optiflow + interfaces are designed for use with the airvo series humidifiers and are also compatible with the fisher & paykel healthcare (f&p) mr850 and 950 humidification system devices.Optiflow + interfaces are intended for use with spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.Optiflow + interfaces are not intended for life support and appropriate patient monitoring must be used at all times.
 
Event or Problem Description
A healthcare facility in china reported that the opt944 optiflow + adult nasal cannula was found damaged during patient use.The healthcare facility reported that the patient's oxygenation decreased.The subject cannula was then replaced and the patient's oxygenation improved.There were no further patient consequences reported by the healthcare facility.Fisher & paykel healthcare (f&p) has requested for further information about the reported event, such as the sequence of events and location of the damaged part of the cannula.F&p will provide a follow up report upon completion of f&p's investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FISHER & PAYKEL HEALTHCARE
Common Device Name
NASAL CANNULA
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
diego vargas banuelos
17400 laguna canyon road
suite 300
irvine, CA 92618
9494341005
MDR Report Key24776304
Report Number9611451-2026-01148
Device Sequence Number9935314
Product Code BTT
UDI-Device Identifier09420012429117
UDI-Public(01)09420012429117(10)2104048995(11)251110
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K162553
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberOPT944
Device Catalogue NumberOPT944
Device Lot Number2104048995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/09/2026
Supplement Date Received by Manufacturer04/16/2026
Initial Report FDA Received Date04/03/2026
Supplement Report FDA Received Date05/14/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/10/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient SexUnknown
-
-